Danielle Singleton
Hematology & Oncology · Hagerstown, MDNPI 1700060233
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.7% of the total across 123 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 34 manufacturers, the largest accounting for just 9.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $2,050 and has fallen 98.5% since, to $31 in 2021. That places this record below the midpoint for hematology & oncology clinicians in MD, where the typical reported total is $2,111.
Across 123 payments — averaging $20.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$244
- E.r. Squibb & Sons, L.L.C.$219
- Johnson & Johnson$215
- Genentech USA, Inc.$214
- Boehringer Ingelheim$187
- Takeda Pharmaceuticals U.S.A., Inc.$149
- plus $1K from 28 others
What the payments were for
- Food & beverage$2,38397%
- Education$823%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 8 | $244 |
| E.r. Squibb & Sons, L.L.C. | 12 | $219 |
| Johnson & Johnson(2 entities) | 14 | $215 |
| Genentech USA, Inc. | 11 | $214 |
| Boehringer Ingelheim | 4 | $187 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $149 |
| Pfizer | 14 | $137 |
| Merck | 7 | $98 |
| Lilly USA, LLC | 5 | $90 |
| Amgen | 4 | $79 |
| Bristol Myers Squibb | 4 | $71 |
| EMD Serono, Inc. | 2 | $56 |
| Daiichi Sankyo Inc. | 2 | $56 |
| Pharmacyclics LLC, An Abbvie Company | 3 | $55 |
| Array Biopharma Inc | 2 | $54 |
| AbbVie | 2 | $47 |
| Tersera Therapeutics LLC | 2 | $44 |
| Novartis | 2 | $43 |
| Sanofi | 2 | $43 |
| Eisai Inc. | 2 | $35 |
| Taiho Oncology, Inc. | 2 | $35 |
| Astellas Pharma US Inc | 2 | $35 |
| Incyte Corporation | 2 | $32 |
| Seagen Inc. | 2 | $31 |
| Exelixis Inc. | 1 | $25 |
| Ipsen Biopharmaceuticals, Inc | 1 | $24 |
| Bayer | 1 | $24 |
| Dendreon Pharmaceuticals LLC | 1 | $23 |
| Acceleron Pharma, Inc. | 1 | $20 |
| Epizyme, Inc. | 1 | $19 |
| Clovis Oncology, Inc. | 1 | $18 |
| Lexicon Pharmaceuticals, Inc. | 1 | $15 |
| Agios Pharmaceuticals, Inc. | 1 | $14 |
| Gilead | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,465 in reported general payments places this provider in the 50th percentile of 242 hematology & oncology providers in Maryland.
Other hematology & oncology in Hagerstown
- Alida EspinozaHagerstown$23K
- Yong TangHagerstown$18K
- Ralph BocciaBethesda$3.1M
- Sandra SwainBethesda$1M
- Kashif AliSilver Spring$987K
- Ani BalmanoukianBaltimore$842K
- Benjamin LevyBaltimore$578K
- Patrick FordeBaltimore$269K
- Noah HahnBaltimore$133K
- Walid El AyassSalisbury$111K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.